On the contrary, as an EGX holder I'm disappointed (naturally of course) that we're not getting a higher bid.
Given the recent acquisitions in the antibody field:
Feb 06 – Abgenix acquired by Amgen – US$2,200 million
May 06 – Cambridge Antibody Technology acquired by Astra Zeneca –
US$1,300 million
July 06 – Amrad/Zenyth acquired by CSL - A$108 million
Dec 06 - Domantis acquired by GSK – US$454 million
April 07 – Morphotek acquired by Eisai – US$325 million
I don't know enough to compare EGX to the above but it must be comparable to Amrad/Zenyth.
- Forums
- ASX - By Stock
- PTD
- merger announcement
PTD
unknown
merger announcement, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online